About James Laur
Form D filings for Gemelli Biotech from 2019 to 2024 list James Laur as director.
James Laur first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name James Laur in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Laur works with at each company, as listed on that company's latest Form D.
Gemelli Biotech Corp. · Form D/A, Dec 2, 2024
JN
John Neczesny
Director
MM
Matthew Mitcho
Chief Executive Officer and director
OL
Oded Levy
Director
RA
Ritish Agarwal
Director